Organotypic reconstructs were grown as previously described [18 (link), 20 (link)] with the exception that each culture was rinsed in 1XPBS and incubated with Epidermalization 3 medium lacking serum for two additional days prior to harvesting. The following treatments were added to the organotypic cultures at the time of epithelial seeding and renewed with every media change: 5 ng/ml recombinant human TGFβ1, 10 ng/ml Activin A, 100 ng/ml Follistatin-288 (all from R&D Systems) or 1 μM A83-01 (Tocris).
Free full text: Click here